Emerson Electric
EMR · Electrical Components & Equipment
$161.59
0.8%Rockwell Automation
ROK · Electrical Components & Equipment
$426.11
0.5%The short version
- Emerson Electric is the larger business, with $18.0B of revenue in fiscal 2025 against $8.3B for Rockwell Automation, about 2.2 times as much.
- Emerson Electric grew revenue faster (3.0%, against 0.9%).
- Rockwell Automation turned more of its sales into free cash flow (16.3% FCF margin, against 14.8% FCF margin).
- Rockwell Automation earned a higher return on the capital invested in it (20.9%, against 7.6%).
- Investors pay more for each dollar of Rockwell Automation’s earnings: a P/E of 39.9x against 35.4x for Emerson Electric.
| Latest fiscal year | EMR · FY25 | ROK · FY25 |
|---|---|---|
| Size | ||
| Market cap | $90.7B | $47.6B |
| Revenue | $18.0B | $8.3B |
| Free cash flow | $2.7B | $1.4B |
| Net income | $2.3B | $869M |
| Growth | ||
| Revenue growth | 3.0% | 0.9% |
| 5-year growth | 1.4% | 5.7% |
| Share count change | −1.3% | −1.2% |
| Profitability | ||
| Gross margin | 52.8% | 48.1% |
| Operating margin | — | 20.4% |
| Net margin | 12.7% | 10.4% |
| FCF margin | 14.8% | 16.3% |
| Return on capital | 7.6% | 20.9% |
| Return on equity | 10.9% | 24.3% |
| Balance sheet | ||
| Net debt | $11.6B | $2.8B |
| Net debt / EBITDA | 2.5x | 1.4x |
| Dividends and buybacks | $2.4B | $1.0B |
| Valuation & quality | ||
| P/E | 35.4x | 39.9x |
| Piotroski F-score | 6 | 8 |
FY16
EMR $14.5B
ROK $5.9B
FY17
EMR $15.3B
ROK $6.3B
FY18
EMR $17.4B
ROK $6.7B
FY19
EMR $18.4B
ROK $6.7B
FY20
EMR $16.8B
ROK $6.3B
FY21
EMR $12.9B
ROK $7.0B
FY22
EMR $13.8B
ROK $7.8B
FY23
EMR $15.2B
ROK $9.1B
FY24
EMR $17.5B
ROK $8.3B
FY25
EMR $18.0B
ROK $8.3B
EMR
ROK
FY16
EMR —
ROK —
FY17
EMR —
ROK —
FY18
EMR —
ROK —
FY19
EMR —
ROK —
FY20
EMR —
ROK —
FY21
EMR —
ROK —
FY22
EMR —
ROK —
FY23
EMR —
ROK 21.3%
FY24
EMR —
ROK 19.3%
FY25
EMR —
ROK 20.4%
EMR
ROK
FY16
EMR $2.4B
ROK $830M
FY17
EMR $1.4B
ROK $892M
FY18
EMR $2.3B
ROK $1.2B
FY19
EMR $2.4B
ROK $1.0B
FY20
EMR $2.5B
ROK $1.0B
FY21
EMR $3.2B
ROK $1.1B
FY22
EMR $2.6B
ROK $682M
FY23
EMR $274M
ROK $1.2B
FY24
EMR $2.9B
ROK $639M
FY25
EMR $2.7B
ROK $1.4B
EMR
ROK
FY16
EMR 15.5%
ROK 50.1%
FY17
EMR 17.0%
ROK 50.7%
FY18
EMR 20.7%
ROK 31.5%
FY19
EMR 19.8%
ROK 37.8%
FY20
EMR 17.0%
ROK 52.6%
FY21
EMR 11.4%
ROK 33.0%
FY22
EMR 10.4%
ROK 16.6%
FY23
EMR 9.4%
ROK 25.6%
FY24
EMR 6.0%
ROK 22.0%
FY25
EMR 7.6%
ROK 20.9%
EMR
ROK
Add another company
Compare up to four at once.
Each company's latest fiscal year; fiscal years end in different months. The best value in each row is highlighted where higher (or lower) is clearly better. Not investment advice.